Kathleen Mcmahon, in Bellevue, NE - Social Worker

Kathleen Mcmahon, is a Social Worker - Clinical based in Bellevue, Nebraska. Kathleen Mcmahon is licensed to practice in Nebraska (license number 709) and her current practice location is 2211 Peoples Rd, Suite 1, Bellevue, Nebraska. She can be reached at her office (for appointments etc.) via phone at (402) 682-9694.

NPI number for Kathleen Mcmahon is 1881858132 and her current mailing address is Po Box 34367, Omaha, Nebraska. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1881858132.

Contact Information

	Kathleen Mcmahon,
	2211 Peoples Rd, Suite 1, Bellevue, NE 68005-4670
	(402) 682-9694
	(402) 682-9678

Healthcare Provider's Profile

Full Name	Kathleen Mcmahon
Gender	Female
Speciality	Social Worker - Clinical
Location	2211 Peoples Rd, Bellevue, Nebraska
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1881858132
Provider Enumeration Date: 07/16/2008
Last Update Date: 07/16/2008

Medical Identifiers

Medical identifiers for Kathleen Mcmahon such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1881858132	NPI	-	NPPES
111324000	Medicaid	NE

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
101YM0800X	Counselor - Mental Health	1167 (Nebraska)	Secondary
1041C0700X	Social Worker - Clinical	709 (Nebraska)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Kathleen Mcmahon is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Kathleen Mcmahon, Po Box 34367, Omaha, NE 68134-0367 Ph: (402) 393-0163	Kathleen Mcmahon, 2211 Peoples Rd, Suite 1, Bellevue, NE 68005-4670 Ph: (402) 682-9694

News Archive

Vertex submits NDA for telaprevir for treating hepatitis C

Vertex Pharmaceuticals Incorporated announced that it has completed the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for telaprevir, Vertex's investigational treatment for people with hepatitis C.

VELCADE sNDA receives FDA approval

Millennium: The Takeda Oncology Company today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE, which expands the label to include long-term (median follow-up 36.7 months) overall survival (OS) data from the landmark VISTA trial and provides specific dosing recommendations for patients with hepatic impairment. The VISTA trial examined the use of VELCADE based therapy in patients with previously untreated multiple myeloma (MM).

Children who receive little to no nutrition during first week in intensive care recover faster

Critically ill children are artificially fed soon after their arrival in intensive care. This common practice is based on the assumption that it will help them recover more quickly. An international study coordinated at KU Leuven, Belgium, has now disproven this theory. The study shows that receiving little to no nutrition during the first week in intensive care makes children recover faster.

Scientists find that blocking hormone reduces stress-induced infertility in female rats

University of California, Berkeley, scientists have discovered that chronic stress activates a hormone that reduces fertility long after the stress has ended, and that blocking this hormone returns female reproductive behavior to normal.

Kathleen Mcmahon, - Counselor in Bellevue, NE